Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• World Health Organization. Weekly epidemiological update on COVID-19-10 August 2022; 2022. Available from: https://covid19.who.int/. Accessed January 20, 2023.
   Google Scholar
• Ng Y, Li Z, Chua YX, et al. Evaluation of the effectiveness of surveillance and containment measures for the first 100 patients with COVID-19 in Singapore 2020. Morb Mortal Weekly Rep. 2020;69(11):307–311.
   PubMed Web of Science ®Google Scholar
• Nussbaumer-Streit B, Mayr V, Dobrescu A, et al. Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review. Cochrane Database Syst Rev. 2020;4:501.
   Google Scholar
• Md Hamzah N, Yu -M-M, See KF. Assessing the efficiency of Malaysia health system in COVID-19 prevention and treatment response. Health Care Manag Sci. 2021;24(2):273–285. doi:10.1007/s10729-020-09539-9
   PubMed Web of Science ®Google Scholar
• Talic S, Shah S, Wild H, et al. Effectiveness of public health measures in reducing the incidence of COVID-19, SARS-CoV-2 transmission, and COVID-19 mortality: systematic review and meta-analysis. BMJ. 2021;375:e068302. doi:10.1136/bmj-2021-068302
   PubMedGoogle Scholar
• Godman B, Haque M, Islam S, et al. Rapid assessment of price instability and paucity of medicines and protection for COVID-19 across Asia: findings and public health implications for the future. Original Research. Front Public Health. 2020:8. doi:10.3389/fpubh.2020.585832
   PubMed Web of Science ®Google Scholar
• Ogunleye OO, Basu D, Mueller D, et al. Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future. Front Pharmacol. 2020;11. doi:10.3389/fphar.2020.01205
   Web of Science ®Google Scholar
• Nejadghaderi SA, Saghazadeh A, Rezaei N. Health care policies and COVID-19 prevalence: is there any association? Int J Health Serv. 2022;52(1):9–22.
   PubMed Web of Science ®Google Scholar
• World Health Organization. In WHO global pulse survey, 90% of countries report disruptions to essential health services since COVID-19 pandemic; 2020. Available from: https://www.who.int/news/item/31-08-2020-in-who-global-pulse-survey-90-of-countries-report-disruptions-to-essential-health-services-since-covid-19-pandemic. Accessed January 20, 2023.
   Google Scholar
• Sabetkish N, Rahmani A. The overall impact of COVID-19 on healthcare during the pandemic: a multidisciplinary point of view. Health Sci Report. 2021;4(4):e386. doi:10.1002/hsr2.386
   PubMedGoogle Scholar
• Papoutsi E, Giannakoulis VG, Ntella V, Pappa S, Katsaounou P. Global burden of COVID-19 pandemic on healthcare workers. ERJ Open Res. 2020;6(2):00195–2020. doi:10.1183/23120541.00195-2020
   PubMedGoogle Scholar
• Khetrapal S, Bhatia R. Impact of COVID-19 pandemic on health system & sustainable development goal 3. Indian J Med Res. 2020;151(5):395–399.
   PubMed Web of Science ®Google Scholar
• Wang Q, Huang R. The impact of COVID-19 pandemic on sustainable development goals – a survey. Environ Res. 2021;202:111637. doi:10.1016/j.envres.2021.111637
   PubMed Web of Science ®Google Scholar
• Manso L, De Velasco G, Paz-Ares L. Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain. ESMO Open. 2020;5(3). doi:10.1136/esmoopen-2020-000828
   Web of Science ®Google Scholar
• Vasquez L, Sampor C, Villanueva G, et al. Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America. Lancet Oncol. 2020;21(6):753–755. doi:10.1016/S1470-2045(20)30280-1
   PubMed Web of Science ®Google Scholar
• Riera R, Bagattini ÂM, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A. Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Global Oncol. 2021;7:311–323. doi:10.1200/go.20.00639
   PubMedGoogle Scholar
• Hawrot K, Shulman LN, Bleiweiss IJ, et al. Time to treatment initiation for breast cancer during the 2020 COVID-19 pandemic. JCO Oncol Practice. 2021:00807. doi:10.1200/op.20.00807
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Khandker SS, Shakil SM, Hossen SM. Gold nanoparticles; potential nanotheranostic agent in breast cancer: a comprehensive review with systematic search strategy. Curr Drug Metab. 2020;21(8):579–598. doi:10.2174/1389200221666200610173724
   PubMed Web of Science ®Google Scholar
• Shinan-Altman S, Levkovich I, Tavori G. Healthcare utilization among breast cancer patients during the COVID-19 outbreak. Palliat Support Care. 2020;18(4):385–391. doi:10.1017/S1478951520000516
   PubMed Web of Science ®Google Scholar
• World Health Organization. The impact of the COVID-19 pandemic on non-communicable disease resources and services: results of a rapid assessment; 2020. Available from: https://www.who.int/publications/i/item/9789240010291. Accessed January 20, 2023.
   Google Scholar
• Mou TJ, Afroz KA, Haq MA, et al. The effect of socio-demographic factors in health-seeking behaviors among Bangladeshi residents during the first wave of COVID-19. Healthcare. 2022;10(3):483. doi:10.3390/healthcare10030483
   Web of Science ®Google Scholar
• Berger NF, Zimmerman BS, Seidman D, et al. Impact of the COVID-19 pandemic on cancer care and quality of life for patients with breast and gynecologic malignancies: a single-center survey-based study. J Patient Exp. 2022;9:23743735221077543. doi:10.1177/23743735221077543
   Google Scholar
• Rodriguez GM, Ferguson JM, Kurian A, Bondy M, Patel MI. The impact of COVID-19 on patients with cancer: a national study of patient experiences. Am J Clin Oncol. 2021;44(11):580–587. doi:10.1097/coc.0000000000000865
   PubMed Web of Science ®Google Scholar
• Dietz JR, Moran MS, Isakoff SJ, et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020;181(3):487–497. doi:10.1007/s10549-020-05644-z
   PubMed Web of Science ®Google Scholar
• Berger-Richardson D, Ko G, Hong NJL. Preparing for the renaissance: treating breast cancer during the COVID-19 pandemic and planning for a safe re-emergence to routine surgical care within a universal health care system. Current Oncol. 2020;27(3):163–168. doi:10.3747/co.27.6699
   PubMed Web of Science ®Google Scholar
• Khandker SS, Godman B, Jawad MI, et al. A systematic review on COVID-19 vaccine strategies, their effectiveness, and issues. Vaccines. 2021;9(12):1387.
   Web of Science ®Google Scholar
• Atieno OM, Opanga S, Martin A, Kurdi A, Godman B. Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future. J Med Econ. 2018;21(9):878–887. doi:10.1080/13696998.2018.1484372
   PubMed Web of Science ®Google Scholar
• Al-Ziftawi NH, Shafie AA, Mohamed Ibrahim MI. Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2021;21(4):655–666. doi:10.1080/14737167.2020.1794826
   PubMed Web of Science ®Google Scholar
• Gershon N, Berchenko Y, Hall PS, Goldstein DA. Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer. Cost Eff Resour Alloc. 2019;17(1):5. doi:10.1186/s12962-019-0174-7
   PubMedGoogle Scholar
• Li J, Wang H, Geng C, et al. Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: a national survey of 8397 patients in the first quarter of 2020. EClinicalMedicine. 2020;26. doi:10.1016/j.eclinm.2020.100503
   Google Scholar
• Salem C, Hajj M-A, Kourié H, et al. Radiology management of a ‘breast unit’ during COVID-19 pandemic: a single institution experience. Future Oncol. 2020;16(35):2917–2922.
   PubMed Web of Science ®Google Scholar
• Ribeiro CM, Correa FM, Migowski A. Short-term effects of the COVID-19 pandemic on cancer screening, diagnosis and treatment procedures in Brazil: a descriptive study, 2019–2020. [Efeitos de curto prazo da pandemia de COVID-19 na realização de procedimentos de rastreamento, investigação diagnóstica e tratamento do câncer no Brasil: estudo descritivo, 2019–2020]. Epidemiol Serv Saude. 2022;31(1):e2021405. doi:10.1590/s1679-49742022000100010
   PubMedGoogle Scholar
• Dabkeviciene D, Vincerzevskiene I, Urbonas V, et al. The impact of the COVID-19 pandemic on cancer patient’s management—Lithuanian cancer center experience. Healthcare. 2021;9(11):1522. doi:10.3390/healthcare9111522
   Web of Science ®Google Scholar
• Kiziltan G, Tumer BKC, Guler OC, Ozaslan C. Effects of COVID-19 pandemic in a breast unit: is it possible to avoid delays in surgical treatment? Int J Clin Pract. 2021;75(12):e14995. doi:10.1111/ijcp.14995
   PubMed Web of Science ®Google Scholar
• Koca B, Yildirim M. Delay in breast cancer diagnosis and its clinical consequences during the coronavirus disease pandemic. J Surg Oncol. 2021;124(3):261–267. doi:10.1002/jso.26581
   PubMed Web of Science ®Google Scholar
• Güler SA, Özkan güler Ö, Şimşek T, Cantürk NZ. Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. Turkish J Surg. 2021;37(3):222–231.
   PubMed Web of Science ®Google Scholar
• Crisan C, Cainap C, Deac A, et al. Decrease of oncological patients’ hospital visits during COVID-19 pandemic; the experience of a tertiary Romanian centre. J BUON. 2021;26(3):1121–1126.
   PubMed Web of Science ®Google Scholar
• Mooghal M, Javaid RH, Khan W, et al. COVID 19 pandemic: effect on management of patients with breast cancer; single center retrospective cohort study. Int J Surg Open. 2021;35:100386. doi:10.1016/j.ijso.2021.100386
   PubMed Web of Science ®Google Scholar
• Decker KM, Feely A, Bucher O, Singh H, Turner D, Lambert P. Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province. Prev Med. 2022;155:106961. doi:10.1016/j.ypmed.2022.106961
   PubMed Web of Science ®Google Scholar
• Dorri NM, Cohen M, Knight S, et al. Comparison with 2019 of breast surgery activity and breast cancer prognostic factors in a French cancer center during the first 6 months of the COVID-19 pandemic. J Surg Res. 2021;4(2):218–228. doi:10.26502/jsr.10020128
   Google Scholar
• Saeki H, Shirabe K, Miyazaki T, et al. Decreased numbers of gastric, colorectal, lung, and breast cancer surgeries performed in 17 cancer-designated hospitals in Gunma Prefecture of Japan during the COVID-19 pandemic. Surg Today. 2022. doi:10.1007/s00595-022-02501-y
   Web of Science ®Google Scholar
• Eijkelboom AH, de Munck L, Vrancken Peeters M-JTFD, et al. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study. J Hematol Oncol. 2021;14(1):64. doi:10.1186/s13045-021-01073-7
   PubMed Web of Science ®Google Scholar
• Mok CW, Melissa Seet YL, Tan S-M. Breast cancer multidisciplinary management during COVID-19 pandemic: experiences and strategies used by a Singapore breast surgical unit. BIO Integration. 2020;1(2):95–100. doi:10.15212/bioi-2020-0012
   Google Scholar
• Shen C-T, Hsieh H-M, Chang Y-L, Tsai H-Y, Chen F-M. Different impacts of cancer types on cancer screening during COVID-19 pandemic in Taiwan. J Formosan Med Assoc. 2022;2022. doi:10.1016/j.jfma.2022.02.006
   Google Scholar
• Kang Y-J, Baek JM, Kim Y-S, et al. Impact of the COVID-19 pandemic on the diagnosis and surgery of breast cancer: a multi-institutional study. J Breast Cancer. 2021;24(6):491–503. doi:10.4048/jbc.2021.24.e55
   PubMed Web of Science ®Google Scholar
• Losurdo P, Samardzic N, Di Lenarda F, de Manzini N, Giudici F, Bortul M. The real-word impact of breast and colorectal cancer surgery during the SARS-CoV-2 pandemic. Updates Surg. 2022. doi:10.1007/s13304-021-01212-2
   Web of Science ®Google Scholar
• Toss A, Isca C, Venturelli M, et al. Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era. ESMO Open. 2021;6(2):100055. doi:10.1016/j.esmoop.2021.100055
   PubMed Web of Science ®Google Scholar
• Vanni G, Tazzioli G, Pellicciaro M, et al. Delay in breast cancer treatments during the first COVID-19 lockdown. A multicentric analysis of 432 patients. Anticancer Res. 2020;40(12):7119–7125. doi:10.21873/anticanres.14741
   PubMed Web of Science ®Google Scholar
• MacInnes EG, Piper J, Tait C, et al. Breast cancer surgery during the COVID-19 pandemic peak in the UK: operative outcomes. Cureus. 2020;12(7):e9280–e9280.
   PubMed Web of Science ®Google Scholar
• Romics L, Doughty J, Stallard S, et al. A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland. Breast. 2021;55:1–6. doi:10.1016/j.breast.2020.11.015
   PubMed Web of Science ®Google Scholar
• Gheorghe A, Maringe C, Spice J, et al. Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: a national population-based modelling study in England, UK. Eur J Cancer. 2021;152:233–242. doi:10.1016/j.ejca.2021.04.019
   PubMed Web of Science ®Google Scholar
• Sprague BL, O’Meara ES, Lee CI, et al. Prioritizing breast imaging services during the COVID pandemic: a survey of breast imaging facilities within the Breast Cancer Surveillance Consortium. Prev Med. 2021;151:106540. doi:10.1016/j.ypmed.2021.106540
   PubMed Web of Science ®Google Scholar
• Yin K, Singh P, Drohan B, Hughes KS. Breast imaging, breast surgery, and cancer genetics in the age of COVID-19. Cancer. 2020;126(20):4466–4472. doi:10.1002/cncr.33113
   PubMed Web of Science ®Google Scholar
• Boyd CJ, Hemal K, Ramesh S, et al. Breast reconstruction during the COVID-19 pandemic: single institution experience from the pandemic’s epicenter in the United States. J Plast Reconstr Aesthet Surg. 2012. doi:10.1016/j.bjps.2022.02.021
   Google Scholar
• Cairns A, Jones VM, Cronin K, et al. Impact of the COVID-19 pandemic on breast cancer screening and operative treatment. Am Surg. 2022;88:1051.
   PubMed Web of Science ®Google Scholar
• Shaheed S-U, Tait C, Kyriacou K, et al. Nipple aspirate fluid—A liquid biopsy for diagnosing breast health. Proteomics Clin Appl. 2017;11(9–10):1700015. doi:10.1002/prca.201700015
   PubMed Web of Science ®Google Scholar
• Shaheed SU, Tait C, Kyriacou K, Linforth R, Salhab M, Sutton C. Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer. Clin Proteomics. 2018;15:3. doi:10.1186/s12014-017-9179-4
   PubMed Web of Science ®Google Scholar
• Jiwa N, Takats Z, Leff DR, Sutton C. Breast health screening: a UK-wide questionnaire. BMJ Nutr Prev Health. 2021;bmjnph-2021–000266. doi:10.1136/bmjnph-2021-000266
   Google Scholar
• Maio F, Tari DU, Granata V, et al. Breast cancer screening during COVID-19 emergency: patients and department management in a local experience. J Pers Med. 2021;11(5). doi:10.3390/jpm11050380
   Web of Science ®Google Scholar
• Tari DU, Santarsiere A, Palermo F, Morelli CD, Pinto F. The management of a breast unit during the COVID-19 emergency: a local experience. Future Oncol. 2021;17(34):4757–4767. doi:10.2217/fon-2021-0243
   PubMed Web of Science ®Google Scholar
• Seely JM, Scaranelo AM, Yong-Hing C, et al. COVID-19: safe guidelines for breast imaging during the pandemic. Can Assoc Radiol J. 2020;71(4):459–469. doi:10.1177/0846537120928864
   PubMed Web of Science ®Google Scholar
• Kennard K, Williams AD, Goldblatt LG, et al. COVID-19 pandemic: changes in care for a community academic breast center and patient perception of those changes. Ann Surg Oncol. 2021;28(9):5071–5081. doi:10.1245/s10434-020-09583-3
   PubMed Web of Science ®Google Scholar
• Wilke LG, Nguyen TT, Yang Q, et al. Analysis of the impact of the COVID-19 pandemic on the multidisciplinary management of breast cancer: review from the American Society of Breast Surgeons COVID-19 and mastery registries. Ann Surg Oncol. 2021;28(10):5535–5543. doi:10.1245/s10434-021-10639-1
   PubMed Web of Science ®Google Scholar
• Cavalcante FP, Novita GG, Millen EC, et al. Management of early breast cancer during the COVID-19 pandemic in Brazil. Breast Cancer Res Treat. 2020;184(2):637–647. doi:10.1007/s10549-020-05877-y
   PubMed Web of Science ®Google Scholar
• Zhang H, Yin J, Wang X, et al. Patients’ responses to the sudden interruption of chemotherapy during the outbreak of the novel coronavirus: a cross-sectional study. Cancer Manag Res. 2021;13:351–358. doi:10.2147/cmar.s274525
   PubMed Web of Science ®Google Scholar
• Sattar AK, Shahzad H, Jabbar AA, et al. A multidisciplinary approach to triage patients with breast disease during the COVID-19 pandemic: experience from a tertiary care center in the developing world. Cancer Rep. 2021;4(1):e1309. doi:10.1002/cnr2.1309
   Google Scholar
• Ilgün AS, Özmen V. The impact of the COVID-19 pandemic on breast cancer patients. Eur J Breast Health. 2022;18(1):85–90. doi:10.4274/ejbh.galenos.2021.2021-11-5
   PubMed Web of Science ®Google Scholar
• Sezer A, Cicin İ, Karadeniz Çakmak G, et al. Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak. Turkish J Surg. 2020;36(2):147–163.
   PubMed Web of Science ®Google Scholar
• Di Lena É, Hopkins B, Wong SM, Meterissian S. Delays in operative management of early-stage, estrogen receptor–positive breast cancer during the COVID-19 pandemic: a multi-institutional matched historical cohort study. Surgery. 2022;171(3):666–672. doi:10.1016/j.surg.2021.10.033
   PubMed Web of Science ®Google Scholar
• Elsamany S, Elbaiomy M, Zeeneldin A, et al. Suggested modifications to the management of patients with breast cancer during the COVID-19 pandemic: web-based survey study. Original Paper. JMIR Cancer. 2021;7(4):e27073. doi:10.2196/27073
   PubMed Web of Science ®Google Scholar
• Gurney JK, Millar E, Dunn A, et al. The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand–a country pursuing COVID-19 elimination. Lancet Reg Health West Pac. 2021;10:100127. doi:10.1016/j.lanwpc.2021.100127
   PubMedGoogle Scholar
• Alpuim Costa D, Nobre JGG, Fernandes JP, et al. Impact of the COVID-19 pandemic on breast cancer management in Portugal: a cross-sectional survey-based study of medical oncologists. Oncol Ther. 2022. doi:10.1007/s40487-022-00191-7
   PubMed Web of Science ®Google Scholar
• Maiti R. Metronomic chemotherapy. J Pharmacol Pharmacother. 2014;5(3):186–192. doi:10.4103/0976-500x.136098
   PubMedGoogle Scholar
• Brenes Sánchez JM, Picado AL, Olivares Crespo ME, García Sáenz JÁ, De La Plata Merlo RM, De La Muela MH. Breast cancer management during COVID-19 pandemic in Madrid: surgical strategy. Clin Breast Cancer. 2021;21(1):e128–e135. doi:10.1016/j.clbc.2020.10.006
   PubMed Web of Science ®Google Scholar
• Dave RV, Kim B, Courtney A, et al. Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study. Br J Cancer. 2021;124(11):1785–1794. doi:10.1038/s41416-020-01234-4
   PubMed Web of Science ®Google Scholar
• Goldbach MM, Burkbauer L, Bharani T, et al. Effectiveness of a short duration of neoadjuvant endocrine therapy in patients with HR+ breast cancer—an NCDB analysis (2004–2016). Ann Surg Oncol. 2021. doi:10.1245/s10434-021-10287-5
   Google Scholar
• Murphy BM, Hoskin TL, Degnim AC, Boughey JC, Hieken TJ. Surgical management of axilla following neoadjuvant endocrine therapy. Ann Surg Oncol. 2021. doi:10.1245/s10434-021-10385-4
   Google Scholar
• Gasparri ML, Gentilini OD, Lueftner D, Kuehn T, Kaidar-Person O, Poortmans P. Changes in breast cancer management during the Corona Virus Disease 19 pandemic: an international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST). Breast. 2020;52:110–115. doi:10.1016/j.breast.2020.05.006
   PubMed Web of Science ®Google Scholar
• Coles CE, Aristei C, Bliss J, et al. International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic. Clin Oncol. 2020;32(5):279–281. doi:10.1016/j.clon.2020.03.006
   PubMed Web of Science ®Google Scholar
• Ramdas Y, Benn C-A, Heerden M. First intraoperative radiation therapy center in Africa: first 2 years in operation, including COVID-19 experiences. JCO Global Oncol. 2020;6:1696–1703. doi:10.1200/go.20.00258
   PubMedGoogle Scholar
• Dowsett M, Ellis MJ, Dixon JM, et al. Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic. Npj Breast Cancer. 2020;6(1):21. doi:10.1038/s41523-020-0168-9
   PubMed Web of Science ®Google Scholar
• Curigliano G, Cardoso MJ, Poortmans P, et al. Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020;52:8–16. doi:10.1016/j.breast.2020.04.006
   PubMed Web of Science ®Google Scholar
• Rocco N, Montagna G, Di Micco R, et al. The impact of the COVID-19 pandemic on surgical management of breast cancer: global trends and future perspectives. Oncologist. 2021;26(1):e66–e77. doi:10.1002/onco.13560
   PubMed Web of Science ®Google Scholar
• Brown JE, Wood SL, Confavreux C, et al. Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: an international perspective and recommendations. J Bone Oncol. 2021;29:100375. doi:10.1016/j.jbo.2021.100375
   PubMed Web of Science ®Google Scholar
• Sadri K, Dabbagh VR, Forghani MN, Asadi M, Sadeghi R. Lymphoscintigraphy in the time of COVID-19: effect of Molybdenum-99 shortage on feasibility of sentinel node mapping. Lymphat Res Biol. 2021;19(2):134–140. doi:10.1089/lrb.2020.0063
   PubMed Web of Science ®Google Scholar
• Vohra LM, Jabeen D, Khan N, Nizar A, Jamil A, Siddiqui T. Analysing the trends in breast surgery practice during COVID-19 pandemic: a comparative study with the Pre-COVID era. Ann Med Surg. 2022;74:103342. doi:10.1016/j.amsu.2022.103342
   PubMed Web of Science ®Google Scholar
• Vohra LM, Jabeen D, Asif N, Ahad A. COVID-19 pandemic and breast cancer management: a retrospective observational clinical study from Pakistan. Ann Med Surg. 2021;63:102151. doi:10.1016/j.amsu.2021.01.099
   PubMed Web of Science ®Google Scholar
• Kara H, Arikan AE, Dulgeroglu O, Tutar B, Tokat F, Uras C. Has the COVID-19 pandemic affected breast cancer stage and surgical volume? Original Research. Front Surg. 2022;9. doi:10.3389/fsurg.2022.811108
   Web of Science ®Google Scholar
• Illmann CF, Doherty C, Wheelock M, et al. The impact of the COVID-19 pandemic on breast reconstruction: a Canadian perspective. Plast Surg. 2021;29(4):287–293. doi:10.1177/22925503211030017
   Google Scholar
• Murris F, Huchon C, Zilberman S, et al. Impact of the first lockdown for coronavirus 19 on breast cancer management in France: a multicentre survey. J Gynecol Obstet Hum Reprod. 2021;50(9):102166. doi:10.1016/j.jogoh.2021.102166
   PubMed Web of Science ®Google Scholar
• Fancellu A, Sanna V, Rubino C, et al. The COVID-19 outbreak may be associated to a reduced level of care for breast cancer. A comparative study with the pre-COVID era in an Italian breast unit. Healthcare. 2020;8(4):474. doi:10.3390/healthcare8040474
   Web of Science ®Google Scholar
• Filipe MD, van Deukeren D, Kip M, et al. Effect of the COVID-19 pandemic on surgical breast cancer care in the Netherlands: a multicenter retrospective cohort study. Clin Breast Cancer. 2020;20(6):454–461. doi:10.1016/j.clbc.2020.08.002
   PubMed Web of Science ®Google Scholar
• Vanni G, Pellicciaro M, Materazzo M, et al. Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency. Breast Cancer. 2021;28(1):137–144. doi:10.1007/s12282-020-01137-5
   PubMed Web of Science ®Google Scholar
• Pellini F, Di Filippo G, Mirandola S, Deguidi G, Filippi E, Pollini GP. Effects of lean thinking and emerging technologies on breast cancer patients’ therapeutic process during COVID-19 pandemic: a case-control matched study. Front Surg. 2021;8(30). doi:10.3389/fsurg.2021.582980
   PubMedGoogle Scholar
• Batt J, Cook N, Nadeem M, Sahu A. Dilutional local anaesthetic techniques in oncoplastic breast surgery and potential benefits during the COVID-19 pandemic and beyond. J Perioper Pract. 2020;30(9):277–282.
   PubMedGoogle Scholar
• Sud A, Jones ME, Broggio J, et al. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol. 2020;31(8):1065–1074. doi:10.1016/j.annonc.2020.05.009
   PubMed Web of Science ®Google Scholar
• Joseph WJ, Bustos SS, Losee JE, Rubin JP, De La Cruz C. The impact of the COVID-19 pandemic on breast reconstruction practices in the United States. Anticancer Res. 2021;41(4):1903–1908. doi:10.21873/anticanres.14956
   PubMed Web of Science ®Google Scholar
• Isaac KV, Buchel EW, Brackstone MM, et al. Canadian expert opinion on breast reconstruction access: strategies to optimize care during COVID-19. Plast Reconstr Surg-Glob Open. 2022;10(2):e4204. doi:10.1097/GOX.0000000000004204
   PubMedGoogle Scholar
• Fregatti P, Gipponi M, Giacchino M, et al. Breast cancer surgery in the COVID-19 pandemic: validation of a preventive program for patients and health care workers. In Vivo. 2021;35(1):635–639. doi:10.21873/invivo.12302
   PubMed Web of Science ®Google Scholar
• Lisa A, Battistini A, Giannasi S, et al. Breast reconstruction in a coronavirus disease 2019 hub. Plast Reconstr Surg-Glob Open. 2020;8(7):e3043. doi:10.1097/GOX.0000000000003043
   PubMedGoogle Scholar
• Abdalla AS, Asaad A, Fisher R, et al. The challenge of COVID-19: the biological characteristics and outcomes in a series of 130 breast cancer patients operated on during the pandemic. Chirurgia. 2020;115(4):458–468. doi:10.21614/chirurgia.115.4.458
   PubMed Web of Science ®Google Scholar
• Specht M, Sobti N, Rosado N, et al. High-efficiency same-day approach to breast reconstruction during the COVID-19 crisis. Breast Cancer Res Treat. 2020;182(3):679–688. doi:10.1007/s10549-020-05739-7
   PubMed Web of Science ®Google Scholar
• Mo A, Chung J, Eichler J, et al. Breast cancer survivorship care during the COVID-19 pandemic within an urban New York Hospital System. Breast. 2021;59:301–307. doi:10.1016/j.breast.2021.07.018
   PubMed Web of Science ®Google Scholar
• Cadili L, DeGirolamo K, Ma CS-Y, et al. The breast cancer patient experience of telemedicine during COVID-19. Ann Surg Oncol. 2022;29(4):2244–2252. doi:10.1245/s10434-021-11103-w
   PubMed Web of Science ®Google Scholar
• Ludwigson A, Huynh V, Myers S, et al. Patient perceptions of changes in breast cancer care and well-being during COVID-19: a mixed methods study. Ann Surg Oncol. 2022;29(3):1649–1657. doi:10.1245/s10434-021-11209-1
   PubMed Web of Science ®Google Scholar
• Marcasciano M, Kaciulyte J, Mori FLR, et al. Breast surgeons updating on the thresholds of COVID-19 era: results of a multicenter collaborative study evaluating the role of online videos and multimedia sources on breast surgeons education and training. Eur Rev Med Pharmacol Sci. 2020;24(14):7845–7854. doi:10.26355/eurrev_202007_22289
   PubMed Web of Science ®Google Scholar
• Sharma P, Chowdhury K, Kumar S, et al. A pilot study regarding the consequences of the COVID-19 pandemic on healthcare education in India and the implications. Original Article. Adv Hum Biol. 2022;12(2):180–189. doi:10.4103/aihb.aihb_34_22
   Web of Science ®Google Scholar
• Etando A, Amu AA, Haque M, et al. Challenges and innovations brought about by the COVID-19 pandemic regarding medical and pharmacy education especially in Africa and implications for the future. Healthcare. 2021;9(12). doi:10.3390/healthcare9121722
   Web of Science ®Google Scholar
• Ho W, Köhler G, Haywood RM, Rosich-Medina A, Masud D. Microsurgical autologous breast reconstruction in the midst of a pandemic: a single-unit COVID-19 experience. J Plast Reconstr Aesthet Surg. 2022;75(1):112–117. doi:10.1016/j.bjps.2021.09.007
   PubMed Web of Science ®Google Scholar
• Wei J, Wu M, Liu J, et al. Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: a multi-center retrospective study in Hubei, China. Breast. 2021;59:102–109. doi:10.1016/j.breast.2021.06.006
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–1918. doi:10.1016/S0140-6736(20)31187-9
   PubMed Web of Science ®Google Scholar
• Kathuria-Prakash N, Antrim L, Hornstein N, et al. Factors associated with hospitalization among breast cancer patients with COVID-19: a diverse multi-center Los Angeles cohort study. Clin Breast Cancer. 2021;2021. doi:10.1016/j.clbc.2021.12.005
   Google Scholar
• Juanjuan L, Santa-Maria CA, Hongfang F, et al. Patient-reported outcomes of patients with breast cancer during the COVID-19 outbreak in the epicenter of china: a cross-sectional survey study. Clin Breast Cancer. 2020;20(5):e651–e662. doi:10.1016/j.clbc.2020.06.003
   PubMed Web of Science ®Google Scholar
• Sokas C, Kelly M, Sheu C, et al. Cancer in the shadow of COVID: early-stage breast and prostate cancer patient perspectives on surgical delays due to COVID-19. Ann Surg Oncol. 2021. doi:10.1245/s10434-021-10319-0
   Web of Science ®Google Scholar
• Soriano EC, Perndorfer C, Otto AK, et al. Psychosocial impact of cancer care disruptions in women with breast cancer during the COVID-19 pandemic. Front Psychol. 2021;12(1878). doi:10.3389/fpsyg.2021.662339
   PubMedGoogle Scholar
• Vanni G, Materazzo M, Pellicciaro M, et al. Breast cancer and COVID-19: the effect of fear on patients’ decision-making process. In Vivo. 2020;34(3suppl):1651–1659. doi:10.21873/invivo.11957
   PubMedGoogle Scholar
• Oishee MJ, Ali T, Jahan N, et al. COVID-19 pandemic: review of contemporary and forthcoming detection tools. Infect Drug Resist. 2021;14:1049–1082. doi:10.2147/idr.s289629
   PubMed Web of Science ®Google Scholar
• Jamiruddin MR, Meghla BA, Islam DZ, et al. Microfluidics technology in SARS-CoV-2 diagnosis and beyond: a systematic review. Life. 2022;12(5). doi:10.3390/life12050649
   PubMedGoogle Scholar